Novel IL-12 family members shed light on the orchestration of Th1 responses

Trends in Immunology

Volumn 24, Issue 4, 2003, Pages 207-212

  Brombacher, Frank ^a   Kastelein, Robert A ^b   Alber, Gottfried ^c  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b MERCK RESEARCH LABORATORIES   (United States)

^c UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 12; INTERLEUKIN 27; INTERLEUKIN DERIVATIVE; PROTEIN P19; PROTEIN P35; PROTEIN P40; UNCLASSIFIED DRUG;

CELLULAR IMMUNITY; EPSTEIN BARR VIRUS; IMMUNOSTIMULATION; INFECTION; MEMORY CELL; NATURAL KILLER CELL; NONHUMAN; PROTEIN FAMILY; PROTEIN SYNTHESIS; REVIEW; T LYMPHOCYTE; TH1 CELL; VIRUS GENE;

EID: 0037385216     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4906(03)00067-X     Document Type: Review

References (66)

1. Gately M.K., et al. The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses. Annu. Rev. Immunol. 16:1998;495-521.
2. Trinchieri G. Interleukin-12: a cytokine at the interface of inflammation and immunity. Adv. Immunol. 70:1998;83-243.
3. Magram J., et al. IL-12-deficient mice are defective in IFNγ production and type 1 cytokine responses. Immunity. 4:1996;471-481.
4. Mattner F., et al. Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2-cell response. Eur. J. Immunol. 26:1996;1553-1559.
5. Park A.Y., et al. IL-12 is required to maintain a Th1 response during Leishmania major infection. J. Immunol. 165:2000;896-902.
6. Yap G., et al. Cutting edge: IL-12 is required for the maintenance of IFNγ production in T cells mediating chronic resistance to the intracellular pathogen, Toxoplasma gondii. J. Immunol. 165:2000;628-631.
7. Merberg D.M., et al. Sequence similarity between NKSF and the IL-6/G-CSF family. Immunol. Today. 13:1992;77-78.
8. Gearing D.P., Cosman D. Homology of the p40 subunit of natural-killer cell stimulatory factor (NKSF) with the extracellular domain of the interleukin-6 receptor. Cell. 66:1991;9-10.
9. Gubler U., et al. Coexpression of two distinct genes is required to generate secreted bioactive cytotoxic lymphocyte maturation factor. Proc. Natl. Acad. Sci. U. S. A. 88:1991;4143-4147.
10. D'Andrea A., et al. Production of natural-killer cell stimulatory factor (interleukin 12) by peripheral-blood mononuclear cells. J. Exp. Med. 176:1992;1387-1398.
11. Presky D.H., et al. A functional interleukin 12 receptor complex is composed of two β-type cytokine receptor subunits. Proc. Natl. Acad. Sci. U. S. A. 93:1996;14002-14007.
12. Kaplan M.H., et al. Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice. Nature. 382:1996;174-177.
13. Thierfelder W.E., et al. Requirement for Stat4 in interleukin-12-mediated responses of natural-killer and T cells. Nature. 382:1996;171-174.
14. Wu C., et al. Characterization of IL-12 receptor β1 chain (IL-12Rβ1)-deficient mice: IL-12Rβ1 is an essential component of the functional mouse IL-12 receptor. J. Immunol. 159:1997;1658-1665.
15. Wu C., et al. IL-12 receptor β2 (IL-12Rβ2)-deficient mice are defective in IL-12-mediated signaling despite the presence of high affinity IL-12 binding sites. J. Immunol. 165:2000;6221-6228.
16. Mattner F., et al. The interleukin-12 subunit p40 specifically inhibits effects of the interleukin-12 heterodimer. Eur. J. Immunol. 23:1993;2202-2208.
17. Heinzel F.P., et al. In vivo production and function of IL-12 p40 homodimers. J. Immunol. 158:1997;4381-4388.
18. Gillessen S., et al. Mouse interleukin-12 (IL-12) p40 homodimer: a potent IL-12 antagonist. Eur. J. Immunol. 25:1995;200-206.
19. Ling P., et al. Human IL-12 p40 homodimer binds to the IL-12 receptor but does not mediate biologic activity. J. Immunol. 154:1995;116-127.
20. Mattner F., et al. Treatment with homodimeric interleukin-12 (IL-12) p40 protects mice from IL-12-dependent shock but not from tumor necrosis factor α-dependent shock. Infect. Immun. 65:1997;4734-4737.
21. Yoshimoto T., et al. Reduced T helper 1 responses in IL-12 p40 transgenic mice. J. Immunol. 160:1998;588-594.
22. Germann T., et al. The IL-12 p40 homodimer as a specific antagonist of the IL-12 heterodimer. Immunol. Today. 16:1995;500-501.
23. Ha S.J., et al. Engineering N-glycosylation mutations in IL-12 enhances sustained cytotoxic T-lymphocyte responses for DNA immunization. Nat. Biotechnol. 20:2002;381-386.
24. + IFNγ-producing cells. J. Immunol. 158:1997;643-648.
25. Piccotti J.R., et al. Alloantigen-reactive Th1 development in IL-12-deficient mice. J. Immunol. 160:1998;1132-1138.
26. Hölscher C., et al. A protective and agonistic funciton of IL-12p40 in mycobacterial infection. J. Immunol. 167:2001;6957-6966.
27. Cooper A.M., et al. Mice lacking bioactive IL-12 can generate protective, antigen-specific cellular responses to mycobacterial infection only if the IL-12 p40 subunit is present. J. Immunol. 168:2002;1322-1327.
28. Oppmann B., et al. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity. 13:2000;715-725.
29. Walter M.J., et al. Interleukin 12 p40 production by barrier epithelial cells during airway inflammation. J. Exp. Med. 193:2001;339-351.
30. Ha S.J., et al. A novel function of IL-12p40 as a chemotactic molecule for macrophages. J. Immunol. 163:1999;2902-2908.
31. Huaux F., et al. A profibrotic function of IL-12p40 in experimental pulmonary fibrosis. J. Immunol. 169:2002;2653-2661.
32. Pahan K., et al. Induction of nitric-oxide synthase and activation of NFκB by interleukin-12 p40 in microglial cells. J. Biol. Chem. 276:2001;7899-7905.
33. Presky D.H., et al. Evidence for multiple sites of interaction between IL-12 and its receptor. Ann. New York Acad. Sci. 795:1996;390-393.
34. Wang X., et al. Characterization of mouse interleukin-12 p40 homodimer binding to the interleukin-12 receptor subunits. Eur. J. Immunol. 29:1999;2007-2013.
35. Zou J., et al. Differential associations between the cytoplasmic regions of the interleukin-12 receptor subunits β1 and β2 and JAK kinases. J. Biol. Chem. 272:1997;6073-6077.
36. Kawashima T., et al. Interleukin-12 induces tyrosine phosphorylation of an 85-kDa protein associated with the interleukin-12 receptor β1 subunit. Cell. Immunol. 186:1998;39-44.
37. Parham C., et al. A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rβ1 and a novel cytokine receptor subunit, IL-23R. J. Immunol. 168:2002;5699-5708.
38. Aggarwal S., et al. Interleukin-23 promotes a distinct CD4 T-cell activation state characterized by the production of interleukin-17. J. Biol. Chem. 278:2003;1910-1914.
39. Wiekowski M.T., et al. Ubiquitous transgenic expression of the IL-23 subunit p19 induces multiorgan inflammation, runting, infertility and premature death. J. Immunol. 166:2001;7563-7570.
40. Decken K., et al. Interleukin-12 is essential for a protective Th1 response in mice infected with Cryptococcus neoformans. Infect. Immun. 66:1998;4994-5000.
41. Lehmann J., et al. IL-12p40-dependent agonistic effects on the development of protective innate and adaptive immunity against Salmonella Enteritidis. J. Immunol. 167:2001;5304-5315.
42. Kopp T., et al. Inflammatory skin disease in K14/p40 transgenic mice: evidence for interleukin-12-like activities of p40. J. Invest. Dermatol. 117:2001;618-626.
43. Pflanz S., et al. IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naïve CD4(+) T cells. Immunity. 16:2002;779-790.
44. Chen Q., et al. Development of Th1-type immune responses requires the type I cytokine receptor TCCR. Nature. 407:2000;916-920.
45. Yoshida H., et al. WSX1 is required for the initiation of Th1 responses and resistance to L. major infection. Immunity. 15:2001;569-578.
46. Szabo S.J., et al. Regulation of the interleukin (IL)-12Rβ2 subunit expression in developing T helper 1 (Th1) and Th2 cells. J. Exp. Med. 185:1997;817-824.
47. Rogge L., et al. Selective expression of an interleukin-12 receptor component by human T helper 1 cells. J. Exp. Med. 185:1997;825-831.
48. Devergne O., et al. A novel interleukin-12 p40-related protein induced by latent Epstein-Barr virus infection in B lymphocytes. J. Virol. 70:1996;1143-1153.
49. Devergne O., et al. Expression of Epstein-Barr virus-induced gene 3, an interleukin-12 p40-related molecule, throughout human pregnancy: involvement of syncytiotrophoblasts and extravillous trophoblasts. Am. J. Pathol. 159:2001;1763-1776.
50. Devergne O., et al. Epstein-Barr virus-induced gene 3 and the p35 subunit of interleukin 12 form a novel heterodimeric hematopoietin. Proc. Natl. Acad. Sci. U. S. A. 94:1997;12041-12046.
51. Nieuwenhuis E.E., et al. Disruption of T helper 2-immune responses in Epstein-Barr virus-induced gene 3-deficient mice. Proc. Natl. Acad. Sci. U. S. A. 99:2002;16951-16956.
52. Mastroeni P., et al. Effect of interleukin 12 neutralization on host resistance and γ interferon production in mouse typhoid. Infect. Immun. 64:1996;189-196.
53. Cooper A.M., et al. Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with Mycobacterium tuberculosis. J. Exp. Med. 186:1997;39-45.
54. Schijns V.E., et al. Mice lacking IL-12 develop polarized Th1 cells during viral infection. J. Immunol. 160:1998;3958-3964.
55. Carr J.A., et al. The role of endogenous interleukin-12 in resistance to murine cytomegalovirus (MCMV) infection and a novel action for endogenous IL- 12 p40. J. Interferon Cytokine Res. 19:1999;1145-1152.
56. Oxenius A., et al. IL-12 is not required for induction of type 1 cytokine responses in viral infections. J. Immunol. 162:1999;965-973.
57. van Den B.M., et al. IL-4 and IL-10 antagonize IL-12-mediated protection against acute vaccinia virus infection with a limited role of IFNγ and nitric oxide synthetase 2. J. Immunol. 164:2000;371-378.
58. Ottenhoff T.H., et al. Novel human immunodeficiencies reveal the essential role of type-I cytokines in immunity to intracellular bacteria. Immunol. Today. 19:1998;491-494.
59. Reis e Sousa C., et al. Conditioning of dendritic cells by pathogen-derived stimuli. Immunobiology. 204:2001;595-597.
60. Schulz O., et al. CD40 triggering of heterodimeric IL-12 p70 production by dendritic cells in vivo requires a microbial priming signal. Immunity. 13:2000;453-462.
61. van Seventer J.M., et al. Interferon-β differentially regulates expression of the IL-12 family members p35, p40, p19 and EBI3 in activated human dendritic cells. J. Neuroimmunol. 133:2002;60-71.
62. + T cells. Nat. Immunol. 3:2002;549-557.
63. Müller U., et al. IL-12-independent IFNγ production by T cells in experimental Chagas' disease is mediated by IL-18. J. Immunol. 167:2001;3346-3353.
64. Elkins K.L., et al. In vivo clearance of an intracellular bacterium, Francisella tularensis LVS, is dependent on the p40 subunit of interleukin-12 (IL-12) but not on IL-12 p70. Infect. Immun. 70:2002;1936-1948.
65. Brombacher F., et al. IL-12 is dispensable for innate and adaptive immunity against low doses of Listeria monocytogenes. Int. Immunol. 11:1999;325-332.
66. Takeda K., et al. Defective NK-cell activity and Th1 response in IL-18-deficient mice. Immunity. 8:1998;383-390.